• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴基斯坦头孢曲松的质量:现状与反响

Quality of ceftriaxone in Pakistan: reality and resonance.

作者信息

Obaid Ali

机构信息

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Karachi.

出版信息

Pak J Pharm Sci. 2009 Apr;22(2):220-9.

PMID:19339236
Abstract

The quality of pharmaceuticals is a global concern, counterfeit/ poor quality/ substandard medicines can cause harms in various ways: In a number of developing countries including Pakistan there is reportedly a high incidence of the availability of substandard drugs. The majority of these reports do not contain quantitative data to support these claims, nor do they describe the methodology employed for the quality assessment. Quality of drugs available in Pakistan are being questioned and topic of discussion in local news paper, TV channels in general public including journalist and physicians due to disparity of price among same generics, lack of knowledge for such science and unknown reasons. Since, quality of drugs can neither be assessed by naked eye or by every one therefore, randomly selected, 96 samples of different strength of injection ceftriaxone sodium and its generic, a widely used third generation cephalosporin in Pakistan since 1982 and 1994 till date respectively included in the said study to know the reality. 15.62% of ceftriaxone injection was found to be out of specification, however, not a single sample was found fake (spurious) out of 96 tested samples. Nevertheless, quality is a wide ranging concept covering all matters that individually or collectively influence the excellence of a product hence price and other related issues are also analyzed in the study.

摘要

药品质量是一个全球关注的问题,假冒/质量差/不合格药品会以各种方式造成危害:据报道,在包括巴基斯坦在内的一些发展中国家,不合格药品的供应发生率很高。这些报告大多没有包含支持这些说法的定量数据,也没有描述用于质量评估的方法。由于同一仿制药之间价格存在差异、公众包括记者和医生缺乏相关科学知识以及不明原因,巴基斯坦市场上药品的质量受到质疑,并成为当地报纸、电视频道上的讨论话题。由于药品质量既不能通过肉眼评估,也不是每个人都能评估,因此,在该研究中随机抽取了96份不同规格的头孢曲松钠注射液及其仿制药样本,头孢曲松钠自1982年起在巴基斯坦广泛使用,其仿制药自1994年至今也在使用,以了解实际情况。结果发现15.62%的头孢曲松注射液不符合规格,但在96份测试样本中未发现一个假药(伪造品)。然而,质量是一个广泛的概念,涵盖所有单独或共同影响产品卓越性的事项,因此该研究还分析了价格和其他相关问题。

相似文献

1
Quality of ceftriaxone in Pakistan: reality and resonance.巴基斯坦头孢曲松的质量:现状与反响
Pak J Pharm Sci. 2009 Apr;22(2):220-9.
2
Pharmaceutical quality of ceftriaxone generic drug products compared with Rocephin.与罗氏芬相比,头孢曲松仿制药的药品质量。
J Chemother. 2003 Aug;15(4):357-68. doi: 10.1179/joc.2003.15.4.357.
3
Pharmaceutical quality of eight generics of ceftriaxone preparation for injection in Eastern Asia.东亚地区八种注射用头孢曲松制剂仿制药的药品质量
J Chemother. 2015;27(6):337-42. doi: 10.1179/1973947814Y.0000000208. Epub 2014 Aug 21.
4
Substandard medicines in resource-poor settings: a problem that can no longer be ignored.资源匮乏地区的劣质药品:一个不容忽视的问题。
Trop Med Int Health. 2008 Aug;13(8):1062-72. doi: 10.1111/j.1365-3156.2008.02106.x. Epub 2008 Jul 8.
5
Pharmaceuticals--strategic considerations in health reforms in Pakistan.药品——巴基斯坦卫生改革中的战略考量
J Pak Med Assoc. 2006 Dec;56(12 Suppl 4):S100-11.
6
Counterfeit and substandard antimalarial drugs in Cambodia.柬埔寨的假冒伪劣抗疟药物。
Trans R Soc Trop Med Hyg. 2006 Nov;100(11):1019-24. doi: 10.1016/j.trstmh.2006.01.003. Epub 2006 Jun 12.
7
[Quality of medicines in least developed countries].[最不发达国家的药品质量]
Med Trop (Mars). 2006 Dec;66(6):533-7.
8
Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence.假冒或不合格抗菌药物:科学证据综述
J Antimicrob Chemother. 2007 Aug;60(2):214-36. doi: 10.1093/jac/dkm109. Epub 2007 Jun 5.
9
Spurious and counterfeit drugs: a growing industry in the developing world.假药和假冒药品:发展中世界一个不断壮大的行业。
Postgrad Med J. 2009 May;85(1003):251-6. doi: 10.1136/pgmj.2008.073213.
10
Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.发展中国家与不合格药品和假药相关的问题:一篇关于自由市场经济中抗逆转录病毒药物时代假药全球影响的综述文章。
East Afr J Public Health. 2008 Dec;5(3):205-10. doi: 10.4314/eajph.v5i3.39004.

引用本文的文献

1
A qualitative exploration of counterfeit, substandard, spurious, and adulterated drugs in Pakistan: A perspective of drug law experts.巴基斯坦假药、劣药、伪药和掺假药品的定性探索:药品法律专家的视角
PLoS One. 2025 Apr 24;20(4):e0322188. doi: 10.1371/journal.pone.0322188. eCollection 2025.
2
Characterizing Medicine Quality by Active Pharmaceutical Ingredient Levels: A Systematic Review and Meta-Analysis across Low- and Middle-Income Countries.基于活性药物成分水平评估药品质量:一项在中低收入国家开展的系统评价和荟萃分析。
Am J Trop Med Hyg. 2022 Jun 15;106(6):1778-1790. doi: 10.4269/ajtmh.21-1123.
3
Identification of Multiple Low-Level Resistance Determinants and Coselection of Motility Impairment upon Sub-MIC Ceftriaxone Exposure in Escherichia coli.
亚抑菌浓度头孢曲松暴露下大肠埃希菌中多种低水平耐药决定因子的鉴定及运动能力损伤的共选择。
mSphere. 2021 Dec 22;6(6):e0077821. doi: 10.1128/mSphere.00778-21. Epub 2021 Nov 17.
4
Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations.巴基斯坦的监管框架:药品质量状况分析及未来建议
J Pharm Policy Pract. 2019 Sep 11;12:23. doi: 10.1186/s40545-019-0184-z. eCollection 2019.
5
Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.中低收入国家不合格和假冒药品的流行情况及经济负担估计:系统评价和荟萃分析。
JAMA Netw Open. 2018 Aug 3;1(4):e181662. doi: 10.1001/jamanetworkopen.2018.1662.
6
Assessment of the price-efficacy relationship for multiple brands of ceftriaxone sodium in Kabul: a cross-sectional study.喀布尔多种品牌头孢曲松钠的性价比关系评估:一项横断面研究。
BMC Res Notes. 2016 Feb 12;9:86. doi: 10.1186/s13104-016-1904-y.
7
Substandard/counterfeit antimicrobial drugs.不合格/假冒抗菌药物。
Clin Microbiol Rev. 2015 Apr;28(2):443-64. doi: 10.1128/CMR.00072-14.